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The p”rpse of this slody was to dotttmim the eueds et 
eaddbettn-1 on tlw comnry wxuhr bed of e,osed that 
pigs. Endothalia-I (3 to 30 pmol/kg body weivdgt) ws 
selectively adndaislered into the left anterior dweadb& 
cormwry artery. Commuy blood Raw and epiwdial vewl 
diameter were m+amwed by qumditattw *riograpby. 
ArterinlprrrrureinerearedafternMpmdllydouaud 
heart rate wm uot ebauge4. 
Cammary bbod Bow and vorwl dteter of tbe I& 
anterior descending artery signifirpour damsrd by 74% 
aad 32%, respectively (p < 0.01 “eraas matrol) after tbe 
So pm&kg dose, wbweas tbeso vartablls modestly de- 
cmnsml in the tefl ctrwmetex artery. B&ottnlin-l in dcea 
of 10 to 30 pm&g prwluced elechwwJ!!&tc ST 
mmnary vmxwnd&iiaa was signiftcaatly in&bite6 after 
treatmeat with iatraveaws dll:lazem (0.2 mg!kg, n = 6) or 
atffdipim (0.1 mgikg, a = 5), but aot after vehicle admbl. 
islraurm III = 4,. 
‘fbb dndy d;mo&ates that lntnrom~nry admb&m. 
urn ate-.I cwses sigtdcmt myouudbd isebemir 
tbro@ cm’cmwy va%wMMt& wltkb ia inhibited by a 
catciMm cbamlel Ma&er. Tbe data S!Jgze¶t tbal aklum 
The vascular endothelium contributes to the regulation of 
vascular tone by releasing endothelium-derived relaxation 
factor OT factors or vasoconstricting agent or agents (l-3). 
Endothelin-I, a newly discovered endothelium-derived pep- 
tide, is known to elicit marked constrictor activity in isolated 
mammalian vessels (4-6). Recently. endathelin has been 
shown (7-10) to produce coronary vasoconsttiction after 
intravenous or intracnmnary administration in open chest 
animals. Despite the potent vasoconstrictor activity in vitro, 
epicardial coronary diameter decreased by <IO’?5 in studies 
in viva (8,9). The mechanism of action of endothelin in the 
coronary vascular bed has not been examined in closed chest 
animals in detail. 
The goal of this study was to determine the direct effects 
of endothelin-1 on the coronary vascular bed of anesthetized 
closed chest pigs in which loss of coronary woreactivity 
due to surgical manipulation appears to be modest ur negli- 
gible. Because most reported studies in vitro have shown the 
vasuwnstrictor activity of endothelin on large conduit ves- 
sels, the diameter of epicardial coronary arteries was mea- 
sured before and after the administration of endothelin-I bv 
means of arteriography. The specific aims were as follows: i) 
We tested the hypothesis that endothelin-I causes coronary 
vasoconstriclion and myocardial iachemia. For this purpose, 
the electrocardiogram (ECG) and oxygen saturation of arte- 
riat and coronary sinus venous blood were measured. 2) We 
examined whether endothelin-I acts on epicardial cornnary 
arteries or small coronary vessels, or both. 3) We explored 
the mechanism of action of endothelin-1 by evaluating the 
effects of two calcium channel blockers. We selected minia- 
ture pigs as an experimental model because their cardiovas- 
cular anatomy and physiology are known to be similar to 
those of humans (I I;. 
Methods 
Experimental preparation. This sf’ldy cor!ormed to the 
Posi!ion of the American Heart Awcciation on Rexarch 
Animal Use adopted in 1984. Fifreel: xdle Yucatan mnua- 
ture pigs (IS to 25 weeks old and IS to 20 kg in weight) rere 
sedated with mtramuscuku ketamme hydrochlonde (IO mp, 
kg) and then anes!helized with 1.0% to 1.5% isoflunne. 
Arterial pH. partial pressure of oxygen (PO,) and panial 
pressure of carbon dioxide (pCO,i were kept within ncrmal 
limits. Physiologic saline solutian (50 mlih) and heparin 
(5 Wo U bolus injection followed by I .ooO U/h) were ccn- 
tinuously infused through a cannula inserted into an ear vem 
during the experiment. After the curatid artery was exposed. 
an SF preshaped Kifa catheter was inserted through the 
artery into the orifice of the lefl coronary artery. Arsenal 
pressure meaxed with a Statham transducer xnd ECC 
leads I, II, aVF, ‘I, and V, were monitored by use of a Gould 
polygraph system and recorded on a multichannel recorder. 
Rectal temperature was maintained at 37.0” to 37.5”C hy an 
external heating pad. In some pigs, a 7F catheter was 
introduced into the wmnarv sinus vein through a iueular I _ 
vein for blood sampling. 
COmMtY arterlography and quantitative analysis. The 
X-ray image intensifier was positioned to obtain a rich, 
anterior oblique projection of the left coronary artery; this 
position was maintained constant throughout the rxperi- 
ment. Cineangiogmms were monitored with a Phillips angio- 
graphic unit and recorded on 35 mm cinefilm at a speed of 50 
framesIs. Nonionic contrast medium (iopamidol 76%. 
Squibb Diagnostic) was used as lhe angiogr<lphic dye. 
The measuremenr of coronary anery diomerer NW prr- 
formed as previously described (12,/3). Briefly. a ccronary 
artery segment was selected from an end-dmstolic frame and 
diameter was measured with digital calipers. The size of the 
angicgraphic catheter was used as a reference standard. 
which allowed diameters to be calibrated in absolute values 
(mm). Transit time required for the contrast medium to pass 
two regions of interest along the proximal left anterior 
descending or circumflex artery was obtained. The value of 
mean blood Row velocity (V) was then calculated IV = 
distances in two regions of interest/transit time). Estimation 
of coronary blood Row (CBFI was made from a value of the 
velocity and a mean arterial cross-sectional area (CSA) at 
regionsof interest (CBF = V X CSA). Previous studies 1141 
have reported that paired mearurements of mean coronary 
blood flow with the method we used versus an epicardial 
electromagnetic flow probe have correlated closely. Percent 
reduction in ecrcnary blood tlou and coronary diameter 
(CD) was estimated as follows: [(CBF UT CD after nitroglyc- 
erin - CBF or CD after endothelin) + (CBF or CD after 
nitmglycerin)] x 100. 
ExperimentalprntneO. Preliminary experiments showed 
that >lW pmo!Jkg doses of intracoronary adminislrarion of 
endcthclln-I caused irrcvers~blc hcmodynamic changes or 
lethal evenx. Thus. we arbitranly utilized 3. IO and 
30 pm&kg do>e\ 10 determine the effects of endothelin-I in 
lhir cludy 
Coronary aneriognphy was perfcrmcd m the contml 
ccnditicn and a few minute, afta intravenous -“;cglycerin 
(0 4 mg) in 811 I5 pigs. Values of vessel diameter and blood 
Row obtained after adainiwation ofnitroglycerin were used 
8s a standard to calculate percent changer of these variables. 
which milv minimize the potsible influence of coronary 
artery tone at resl on the resuks. Thiny minutes after the 
~mtroglyccnn study. endothelin-l in doses of 3. 10 and 
30 pmol!kg wa, administered into the left antericr descend- 
mg artery. lnrracorcnary administralion was performed by 
means of n ?F radiopaquc caiheter that was introduced 
thrcueh the K!fa catheter and positioned in the proximal 
vecsel wnh the aid of tluoroscopy. Coronxy anencgnphy 
was performed routinely I to 3 mm after each dcse when 
endothelin-induced ST segmenl changes were at the mani- 
mal Icvsl. Bolus injection was ccmplcwd in 30 s and the 
volume of each injecrion was cl ml. Each bclus dose was 
followed bj a IO min observation period. Measuremenrs of 
lefl acrenor descending artery diameter and flow were 
performed an a coronary segment distal to the infusion 
catheter Oxygen saturalion of systemic arterial and coro- 
nary Gnu< venuus blood samples was measured before and 
@ter the 30 pmoUkg dose of endothelin-I. To assess Ihe time 
course of the effects of endothelin-I. coronary nngiograms 
were fhen performed at IO min intervals after the ccntrcl 
study. 
ztfrcr (I 60 nrin period ws allowed for wznrhoar. endothe- 
lin-l challenge was repeated IO min aFter pretreatment with 
snline qolulicn fn = 41, intravenous diltiazem(0.2 mglkg. n = 
6) or nl ‘edlpinc (0. I mglkg. n = 5). 
5&r !tion of ixkmk changes on ECG. At the end of the 
study. the infusion catheter was removed and replaced by a 
2F balloon catheter. which was pOsitioned at the proximal 
left anlerior descending anery. The balloon was then inflated 
For 3 min while the ECG was recorded. We defined sienifi- 
cant ischcmic changes as ST segment elevation or depres- 
sion >0.2 mV lasting for 30 E in lead I or V,. or both. All 
animals developed significant changes after balloon ccclu- 
sion of the left anterior descending artery by this criterion. 
Drugs. Pure synthetic endotkelin-I (Pepride Intema- 
nonull was dissolved in sterile distilled water in a concen- 
tration c; lCn1 +moliml and stored at 0°C until used. NiFe- 
dipine and dlltlazem were puxhased From Sigma Chemicals. 
Stntistioal am&s. Data were expressed as mean values 
+ SEM. Analvsis of variance for revealed mewre~ or 
Student’s I red was used to test equi;alence of kemody- 
namic variables. coronary blood flow and coronary diame- 
rers. When a significant difference was detected. multiple 
comparison I tests were applied. The incidence of ischemic 
ST changes was analyzed by Fisher’s exact test. A proba- 
bility 40.05 was considered to be significant. 
ReSUltS 
Effects of endothettn-1 on the nnoonry varuku bed. 
Administration of vehicle into the left anterior descending 
artery had no effect. Arterial pressure did not change after I 
and 10 pmoVkg doses, but it increased after 30 pmolikg. 
I-!eart .ra:c did not change until significant isckemia devel- 
oped. lntracoronary administration of endothelin-I pro- 
duced dowrelated increases in the incidence ofisckemic ST 
segment change in lead I or V,. or both; 2. IO and 14 of the 
I5 pigs showed significant ST changes ufter 3, IO and 
30 pmoUkg doses. respectively (Table II. These ischemic ST 
changes began at 20 to 30 s after initiation of administration 
and continued for 2.5 ? 0.S mitt after the IO pm&g dose 
and 3.8 2 0.4 min atIer the 30 pmollkg dose. Oxygen 
saturation af the coronary sinus ~cnous blood was signifi- 
candy (p < 0.01) decreased from 56 z 4% in the control 
cowjition to 25 + 3% during ischemic ST elevation induced 
by 30 pmolikg of endothelin-I: arterial oxygen saturation 
remained unchanged (n = 5). 
Coronary angiograma obtained after odminiworion OJ 
endorhelin-I showed delayed filling of contrast medium into 
the peripheral left anterior descending artery (Fig. I). COD 
nary blood Row atang this artery decreased in a dose- 
dependent manner after 3. IO and 30 pm&kg of endothe- 
lin-I, whereas that along the left circumflex artery modestly 
but significantly decreased after IO and 30 pm&g doses 
(Tables 1 to 4). Endotkelin-t also produced dowrektted 
reductions in left anterior descending anery diameter; kow- 
ever, the level of diameter reduction after the 30 pm&kg 
dose was as much as 32 + 4%. The left circumflex artery 
diameter slightly but significantly decreased only after 
Fii 1. Serial aag&rarno (enddiastolic frames) and electracar- 
dwarns (ECG) before WI) and after (rIghI) intracomnary admin- 
i:Lmlion ol endolhelin-I. After endothclin-I. the fillin& of the con. 
ttmst agent into the peripheral kR anterior derccnding coronary 
anery was markedly delayed comtwd widt that into the kh 
CireumAex coronary arlncry. Tldhis finding was assuciatcd with my* 
eardial irchcmia as dcmonslmtcd by sjifieanl regional changes in 
the ST segment OR the ECG. The lnac vnnlw&d indicates the site 
of eadothelin administradon. The smalt -indicate the site of 
lilting delay on the contrast agent. As@&&.8 show the left amrrior 
descendin& coronary artery. 
30 pmolikg of endotkelin-I. The endntkelin-induced diame- 
ter reduction recovered to the baseiine level by IO min after 
either Ike 3 Or the IO pm&kg dose and by 40 min der the 
30 pmolikg dose. 
Effects uf diltlmzem or ntfcdtpine w cndc&cttn.ind~ 
vawuwrkdun and txhemta (Fit. 2 amt 3). Control expsr- 
iments with repeated administration of endotbeliu-I (Table 
2) showed that hemndynamic variables. ~ronary artery 
diameter and coronary blood flow in response IO endothe- 
Iin.1 in the doses we used were simila:after the drst and the 
second administration of Ihe peptide. In experiments where 
the effects of 0.2 mgIkg of dikiazem (Table 3. Fit. 2) and 
0.1 m&of nifedipine (Table 4. Fit. 3) were ,;ludied. mean 
arterial pressure significantly decreased to a similar extent 
after either dikiazem or nifedipine. Heari rate was not 
significanlly changed by diltiazem. but it increased after 
nifedipine. A :ligkt but significant increase in coronary 
diameter and blood Row was observed der diltiazcm and 
nifedipine administration. Percen; reduction in epicardial 
vessel diameter of the left anterior descending anery. in- 
duced by IO and 30 pmoVkg doses of endothelin-t, was 
inhibited akr pretreatment with dibiazem or nifedipine 
(Fig. 2 and 3). Inhibition of coronary blood Row in !he left 
anterior descending artery by dihiazcm or nifcdioine war 
noted a1 3 and IO pklf’kg doses. bul was not s&at Ihe 30 
pmollkg dose. These inhibitory effects vmduced bv aib- 
&em and nifedipine appeared~similar. &dothelin-induced 
reductions in coronary vessel diameter and blood Row in the 
left circumflex artery were not statistically affected by dilt- 
iazem or oifedipine. Arterial pressure and hear! rate re- 
senses to endothelin-I were stable after diltiazcm or nifc- 
&pine. 
The incidence of ischemic ST rhongrs induced by IO 
pmolikg of endothelin-I was decreased after pretreatment 
with diltiazem or nifedipine. whereas lhal produced by the 
30 pmolkp dose eras not ~ti~h~tkdly reduced (Table 11. 
Neither +rauon of the ischemic ST changes nor lime to Ihc 
onset ofixhemia WRS ticcted afler Irez!mrfi! with lhese IWO 
calcium channel blockers. 
Endutllelin and myocardkd ishernia. One result of the 
present ady. showing that decreased coronary blood Ron 
induced by intracomnary adminislralion of endorhelin-l 
with stable or iweased arteriai prcsww. indicates that 
coronary vascular rcsirlance signifiianlly increased in re- 
sponse Lo endothelin-I. The ECG ischemic changes and 
oxygen desaturation in coronary sinus venous blood suggest 
that decreased coronary Row was due to an active constric- 
tion of coronary vessels rather ihan to a reduction in 
myocardial oxvw! reauirement~. Available oublished data 
(6j have oat sl&n a negative inotropic effect on the bean. 
These results suggest that rricomolar doses of endothelin-I 
produced a s&i&ant de&ease in coronary blood flow 
associated with myocardial &hernia by constricting core- 
nary vessels. These data confirm previous studies (7-9) in 
anesthetized open chest animals. However, the unique ac- 
tions of endothelin-I on the coronary vascular bed were 
obtained with bolos administration of exogenous compound, 
and the selected doses were determined empirically on the 
basis of the irreversible responses to doses >IM) pm&kg. 
These doses may be higher than those occurring naturally in 
viva, raising the possibility that the coronary vascular R- 
sponse to the peptide that occurs in physiologic or patho- 
physiologic conditions might not be equivalent to that ob- 
served in the present study. 
Varoeonstrietion of large versus small coronary vezsets. It 
has been demonstrated that endothelin produces potent 
constriction not only in isolated conduit vessels (4-6). but 
also in small vessels (15,16). Thus, we attempted to differ- 
entiate the level of coronary artery that is responsible for 
producing myocardial ischemia. For this purpose, coronary 
arteriography was utilized because t,k technique provides a 
means to evaluate woreactivity on the entire epicardial 
coronary vessel tree in closed chest animals without the 
need of surgical dissection around coronary vessels. In the 
present study. when decreased coronary blood Row with 
significant ischemic changes was observed. the degree ,of 
epicardial diameter reduction was as much as 32%. On a 
theoretic basis (l7), the degree of endothelin-induced oar- 
rowing of the epicardial coronary artery observed in our 
study wa not great enough to significantly decrease core- 
nary blood Row and render tite perfused myocardium ische- 
mic. Therefore, it appears reasonable to conclude that the 
preferential site of endothelin-induced constriction with the 
doses we used is at the level of the small coronary arteries 
rather than epicardial arteries. It is plaosible to assume that 
higher doses of the peptide would cause intense vasocoo- 
striction at levels from epicardial to small coronary vessels 
because the degree of vasoconstriction would depend on the 
doses administered. 
These findings are compatible in part with studies in open 
chest dogs (8,9); however, our results differ from those 
studies (8,9) with regard to the greater degree of constriction 
of the epicardial vessels into which endothelin was adminis- 
tered (32% versw 9.6% and 0% diameter reduction, respec- 
tively. in the previous studies). These differences mav be 
ascribed not bnly to differences in species, but al& to 
variations in experimental conditions (closed versus open 
chest). 
Compariran with other woeonsteietor agents. Among 
vasxonstrictor agents that have been reported to produce 
corooary vasoconstrictionin viva, theeffectsofendothelin-l 
appear to be similar to those of vasopressin (IS), angiotensin 
II (19) and leukotriene (13); especially in large doses (that is, 
pm&kg doses), they produce similar cffers on the coronary 
vasculature as have been shown with endothelin-I in this 
study. However, in terms of effective doses, endothelin-I 
appears to be a more patent coronary constrictor than those 
agents. Indeed. in vitro studies (4-6) of mammalian vascular 
tissues have shown lhat endothelin-I is the most potent 
vasoconstrictor described to date. 
Elfects of ealdum channel bhwiters. Unlike sustained 
vasoconstrictor activities of endothelin-I shown in isolated 
pig coronary arteries and prolonged pressor effects in the rat 
in viva t4.6). the present study showed that coronary vaso. 
constrictor responses to pm&kg doses of inttacoranary 
endothelin-I were transient and reversible. In this regard. 
Ezra et al. (7) reported that the decrease in coronary blood 
flow was transient after intracoronary administration of 
endothelin-1 in doses up to 30 pmollkg. Moreover. our 
control study, with repeated adminiaation of the peptide in 
the absence of any antagonists. suggests that tachyphylaxts 
of coronary constrictor responses to endathelin-I did not 
occur in our experimental pmtocol. 
voltage-dependent ion channel has been postulated as a 
mechanism (4); however, it was found more recently that 
endorhetm-l mav have B soecitic recemor on the sarcolemma 
(201 and may r&kc va&onstrict& by activating intracel- 
Iolar calcium mobilization U-23). The present study dem- 
onstrates that endolhelin-induced epicardial vessel narrow- 
ing and diminution in coronary blood flow WCR significantly 
inhibited by pretreatmelrt with the calcium channel blockers 
diltiazem and nifedipine. Inhibition by thee calcium channel 
blocker, oi epicardial vessel consl.ttion was predominivntly 
noted at B 30 pmollkg dose. whereas the inhibition of 
reduction in cor~nery blood Rnw was observed at 3 and 
10 pmol/kg doses of endothelin-I. The inhibitory effects 
produced by diltiazem and nifedipine appeared similar with 
the doses used. Although further analysis witb regard to the 
vascular m.:chanism of action of endothelin-I is required, it 
is reasonable to propole from our data that calcium influx 
through calcium channels (the voltage-dependent or recep 
ior-operated calcium channels, or both) appears to be in- 
volved at least in par! in the mechanism of endothelin- 
induced coronary vasoconstriction in viva. 
Lintitatiotts of Ihe stttdv. The ~resettt study has limita- 
tions. 1) Estimation of coronary blood flow hi calculating 
the transit time of the contrast agent is subject to error 
(16.17). However, by stindardizingthe volumeas well as the 
period of Iojcstion, the relative changes in transit time in 
each animal can te assessed with acceptable accuracy. A 
published experiment (13) has shown that this measurement 
is applicable to evaluation of changes in blood flow in 
response to vasoconstrictor agents. 2) Because :he contrast 
material ie known to cause modest vasodilation by itself, 
estimation of coronary b&d flow by the technique we used 
might lead to underestimation of actual changes in corotwy 
bload Row. Howew, the percent changes in coronary blood 
flow after endothelin-I that we observed are comparable 
with those reported in a study in open chest pigs (7). 
3) Whether rndothclin is produced in enough quantity in situ 
to produce effects similar to our results in unknown. Thus, 
although pic,molar doses of exogenous compound were 
actually effective enough to produce vasoconstriction and 
ischemia. specific physiologic meaning of the present study 
awaits confimtation. 
Clittical implications. The effects of endothelin-I on the 
coronary vascular bed in pigs were unique in that picomolar 
doses of exogenous cndothelin-1 caused myocardial ische- 
mia through coronary vasoconstriction. The clinical impli- 
cations of the present study are equivocal at the present 
time, hut would be greatly enhanced when the precise nature 
of the production and release of endothelin-I in situ is 
clarified. Indeed, more recent studies (24) demonstrated that 
endothelin-I release orgene expression in endothelial cells is 
stimulated by thrombin, epincphrine, A23187, phorbol esters 
and shear stress, implying that various stimuli on endothelial 
cells might be associated with enhanced endothelin-I release 
(25). We speculate, therefore, that endothelin-I may have a 
role in physiologic and palhophysiologic control of vascular 
tone and coronary blood Row. Coronary vasospasm is 
known to occur primarily in diseased vessels with athero- 
sclerotic plaque (12,25,26), where defective endothelial func- 
tion and hyperreactive contraction of smooth muscles are 
present (12,13.25-27). In these pathologic circumstances, 
endothelin-1 could be a contributory factor in causing coro- 
ttary vasospasm. Moreover, our results provide data of 
potential therapeutic usefulness by showing the preventive 
effects of calcium channel blockers on endothelin-induced 
coronary vasoconstriction. 

